ROSEN, NATIONAL TRIAL LAWYERS, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDCPRNewsWire • 05/13/24
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDCPRNewsWire • 05/05/24
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDCPRNewsWire • 04/29/24
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDCPRNewsWire • 04/20/24
LFCR INVESTOR NEWS: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDCPRNewsWire • 04/13/24
Lifecore Biomedical to Participate in the Stephens Annual Investment Conference on Thursday, November 17, 2022GlobeNewsWire • 11/10/22
Landec Corporation Revises First Quarter 2023 Earnings Conference Call for October 6, 2022 at 8:00 a.m. ETGlobeNewsWire • 09/28/22
Landec Corporation Sets First Quarter 2023 Earnings Conference Call for October 5, 2022 at 2:00 p.m. PTGlobeNewsWire • 09/21/22
Landec Corporation (LNDC) CEO Jim Hall on Q4 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/11/22
Landec Corporation Sets Fourth Quarter 2022 Earnings Conference Call for August 10, 2022 at 2:00 p.m. PTGlobeNewsWire • 07/27/22
Landec Corporation (LNDC) CEO Albert Bolles on Q3 2022 Results - Earnings Call TranscriptSeeking Alpha • 04/06/22
Landec Corporation (LNDC) CEO Albert Bolles on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 01/06/22